GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Shiller PE Ratio

PHCUF (PhotoCure ASA) Shiller PE Ratio : (As of Apr. 12, 2025)


View and export this data going back to . Start your Free Trial

What is PhotoCure ASA Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PhotoCure ASA Shiller PE Ratio Historical Data

The historical data trend for PhotoCure ASA's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Shiller PE Ratio Chart

PhotoCure ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PhotoCure ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PhotoCure ASA's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Shiller PE Ratio falls into.


;
;

PhotoCure ASA Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PhotoCure ASA's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, PhotoCure ASA's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.019/134.8000*134.8000
=-0.019

Current CPI (Dec. 2024) = 134.8000.

PhotoCure ASA Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.064 99.200 -0.087
201506 -0.065 100.100 -0.088
201509 -0.028 100.600 -0.038
201512 -0.051 100.900 -0.068
201603 -0.004 102.500 -0.005
201606 0.101 103.800 0.131
201609 0.000 104.200 0.000
201612 0.097 104.400 0.125
201703 -0.038 105.000 -0.049
201706 -0.026 105.800 -0.033
201709 -0.060 105.900 -0.076
201712 -0.072 106.100 -0.091
201803 -0.018 107.300 -0.023
201806 -0.097 108.500 -0.121
201809 -0.027 109.500 -0.033
201812 -0.064 109.800 -0.079
201903 -0.027 110.400 -0.033
201906 -0.028 110.600 -0.034
201909 -0.003 111.100 -0.004
201912 0.216 111.300 0.262
202003 -0.079 111.200 -0.096
202006 -0.039 112.100 -0.047
202009 -0.025 112.900 -0.030
202012 0.032 112.900 0.038
202103 0.067 114.600 0.079
202106 -0.047 115.300 -0.055
202109 -0.031 117.500 -0.036
202112 -0.117 118.900 -0.133
202203 -0.093 119.800 -0.105
202206 -0.070 122.600 -0.077
202209 -0.036 125.600 -0.039
202212 -0.080 125.900 -0.086
202303 -0.041 127.600 -0.043
202306 0.015 130.400 0.016
202309 -0.017 129.800 -0.018
202312 0.044 131.900 0.045
202403 -0.027 132.600 -0.027
202406 0.042 133.800 0.042
202409 -0.012 133.700 -0.012
202412 -0.019 134.800 -0.019

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PhotoCure ASA  (OTCPK:PHCUF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PhotoCure ASA Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA Business Description

Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.